Issue 6 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

29

No.

6

June 30, 2006Jun 30, 2006

Free

DOWNLOAD THE PDF

ASCO Annual Meeting: New Approaches For Treatment of Hematologic Malignancies

ASCO Updates Guideline On Antiemetics

New Drug Combination Shrinks Kidney Cancers

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

BRCA2 Carriers Reduced BC Risk By Prophylactic Surgery

Communication Is Key To Clinical Trial Enrollment

FDA Approves Treatment For Late-Stage Cervical Cancer

NCI-Approved Clinical Trials

Recent Issues

Volume 52 | Issue 30 - July 31, 2026

Volume 52 | Issue 29 - July 24, 2026

Volume 52 | Issue 28 - July 17, 2026

Volume 52 | Issue 27 - July 10, 2026

Volume 52 | Issue 26 - July 02, 2026

Volume 52 | Issue 25 - June 26, 2026